Cellectis S. A. , a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells.
Cellectis Sa stock last closed at $2.65, down 0.75% from the previous day, and has increased 30.22% in one year. It has overperformed other stocks in the Biotechnology industry by 0.35 percentage points. Cellectis Sa stock is currently +175.18% from its 52-week low of $0.96, and -29.76% from its 52-week high of $3.77.
There are currently 55.58M CLLS shares outstanding. The market cap of CLLS is $147.30M. In the past 24 hours, 44,022 CLLS shares were traded.
How to Buy Cellectis Sa Stock
Not sure how to invest in Cellectis Sa stock? Here's how.
Choose where to buy Cellectis Sa stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Cellectis Sa stock.
Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Deposit funds into your brokerage account: Choose your payment method and add your details.
Analyze Cellectis Sa stock: The Cellectis Sa ticker symbol is CLLS. Is Cellectis Sa stock a good investment? Should you buy shares of CLLS? How do CLLS's underlying business fundamentals look? Do top analysts think Cellectis Sa is a good buy? Why has CLLS's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if CLLS is a good stock to buy).
Execute your CLLS trade: Decide if you will purchase CLLS shares at the current market price or use a limit order to purchase CLLS stock at a particular price.
Keep tabs on your CLLS investment: Create a watchlist to important notifications about your new investment in Cellectis Sa shares.
Step 1: Choose where to buy Cellectis Sa stock
You need an online brokerage account in order to access the NASDAQ market and buy CLLS shares.
A brokerage account enables you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to global financial markets: From Tech to Industrials, New York to London — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've picked the best brokerage, it's time to fill out some personal info so you are able to invest in CLLS today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Cellectis Sa stock
Once you have chosen the best place to buy Cellectis Sa stock, it's critical to research their stock before you buy, so you truly understand the risk and upside.
Cellectis Sa shares at a glance
CLLS Price
$2.65
1w %
4.74%
1y %
30.22%
5y %
-85.39%
P/E
-1.61x
P/B
1.93x
P/S
6.04x
PEG
N/A
Revenue
$24.41M
Earnings
-$85.01M
Fore. Rev. Growth
55.61%
Fore. Earn. Growth
N/A
Market Cap
$147.30M
Next Earnings
May 8, 2024
Next Dividend
N/A
Cellectis Sa Overview
WallStreetZen was built to help part-time investors perform better fundamental analysis in minutes instead of hours.
Last year, CLLS revenue was $24.41M. During the last 5 year, CLLS's revenue has grown by -0.84% per year. This was slower than the Biotechnology industry average of 29.51%.
No, Cellectis Sa doesn't provide an income stream by paying out dividends.
CLLS Social Trading Data
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your CLLS trade
You have two primary types of orders:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are generally the easiest way to buy.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to make sure you're buying or selling at a specific price, use a limit order.
Hit the Open button and your broker will execute the order.
If you need additional assistance investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Cellectis Sa share?
As of Mar 28, 2024, it costs $2.65 to buy one share of Cellectis Sa stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.377 shares of CLLS.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.